http://www.stockbloghub.com Start Your Investing Research Here! Wed, 23 May 2012 20:22:08 +0000 en hourly 1 http://wordpress.org/?v=3.3.2 http://www.stockbloghub.com/2012/03/07/alks-risk-reward-balanced-at-alkermes-analyst-blog/94426 http://www.stockbloghub.com/2012/03/07/alks-risk-reward-balanced-at-alkermes-analyst-blog/94426#comments Wed, 07 Mar 2012 17:19:48 +0000 vitalstocks http://www.stockbloghub.com/?p=94426 http://www.stockbloghub.com/2012/03/07/alks-risk-reward-balanced-at-alkermes-analyst-blog/94426/feed 0 http://www.stockbloghub.com/2011/10/25/amln-amylin-pharmaceuticals-posts-lower-loss/85689 http://www.stockbloghub.com/2011/10/25/amln-amylin-pharmaceuticals-posts-lower-loss/85689#comments Tue, 25 Oct 2011 17:38:34 +0000 vitalstocks http://www.stockbloghub.com/?p=85689 http://www.stockbloghub.com/2011/10/25/amln-amylin-pharmaceuticals-posts-lower-loss/85689/feed 0 http://www.stockbloghub.com/2011/09/19/nvo-novo-nordisk-data-presented-at-european-association-for-the-study-of-diabetes/83265 http://www.stockbloghub.com/2011/09/19/nvo-novo-nordisk-data-presented-at-european-association-for-the-study-of-diabetes/83265#comments Mon, 19 Sep 2011 20:38:19 +0000 vitalstocks http://www.stockbloghub.com/?p=83265 http://www.stockbloghub.com/2011/09/19/nvo-novo-nordisk-data-presented-at-european-association-for-the-study-of-diabetes/83265/feed 0 http://www.stockbloghub.com/2011/09/01/alks-alkermes-analyst-maintains-neutral-rating-on-shares/82387 http://www.stockbloghub.com/2011/09/01/alks-alkermes-analyst-maintains-neutral-rating-on-shares/82387#comments Thu, 01 Sep 2011 16:55:04 +0000 vitalstocks http://www.stockbloghub.com/?p=82387 http://www.stockbloghub.com/2011/09/01/alks-alkermes-analyst-maintains-neutral-rating-on-shares/82387/feed 0 http://www.stockbloghub.com/2011/07/05/nvo-novo-nordisk-presents-late-stage-degludec-data/78249 http://www.stockbloghub.com/2011/07/05/nvo-novo-nordisk-presents-late-stage-degludec-data/78249#comments Tue, 05 Jul 2011 14:06:33 +0000 vitalstocks http://www.stockbloghub.com/?p=78249 http://www.stockbloghub.com/2011/07/05/nvo-novo-nordisk-presents-late-stage-degludec-data/78249/feed 0 http://www.stockbloghub.com/2011/06/29/nvo-novo-nordisk-presents-diabetes-study-data/77767 http://www.stockbloghub.com/2011/06/29/nvo-novo-nordisk-presents-diabetes-study-data/77767#comments Wed, 29 Jun 2011 16:42:38 +0000 vitalstocks http://www.stockbloghub.com/?p=77767 http://www.stockbloghub.com/2011/06/29/nvo-novo-nordisk-presents-diabetes-study-data/77767/feed 0 http://www.stockbloghub.com/2011/06/22/amln-amylin-pharmaceuticals-partners-eli-lilly-and-alkermes-learn-bydureon-gains-eu-approval/77181 http://www.stockbloghub.com/2011/06/22/amln-amylin-pharmaceuticals-partners-eli-lilly-and-alkermes-learn-bydureon-gains-eu-approval/77181#comments Thu, 23 Jun 2011 01:06:34 +0000 vitalstocks http://www.stockbloghub.com/?p=77181 http://www.stockbloghub.com/2011/06/22/amln-amylin-pharmaceuticals-partners-eli-lilly-and-alkermes-learn-bydureon-gains-eu-approval/77181/feed 0 http://www.stockbloghub.com/2011/04/18/amln-amylin-pharmaceuticals-eli-lilly-and-alkermes-get-positive-opinion-for-bydureon/71813 http://www.stockbloghub.com/2011/04/18/amln-amylin-pharmaceuticals-eli-lilly-and-alkermes-get-positive-opinion-for-bydureon/71813#comments Tue, 19 Apr 2011 03:32:34 +0000 vitalstocks http://www.stockbloghub.com/?p=71813 http://www.stockbloghub.com/2011/04/18/amln-amylin-pharmaceuticals-eli-lilly-and-alkermes-get-positive-opinion-for-bydureon/71813/feed 0 http://www.stockbloghub.com/2011/03/28/amln-amylin-pharmaceuticals-releases-disappointing-data/68116 http://www.stockbloghub.com/2011/03/28/amln-amylin-pharmaceuticals-releases-disappointing-data/68116#comments Mon, 28 Mar 2011 22:25:52 +0000 vitalstocks http://www.stockbloghub.com/?p=68116 http://www.stockbloghub.com/2011/03/28/amln-amylin-pharmaceuticals-releases-disappointing-data/68116/feed 0 http://www.stockbloghub.com/2010/11/12/amln-amylin-pharmaceuticals-reports-wider-loss/59006 http://www.stockbloghub.com/2010/11/12/amln-amylin-pharmaceuticals-reports-wider-loss/59006#comments Fri, 12 Nov 2010 19:44:24 +0000 vitalstocks http://www.stockbloghub.com/?p=59006 http://www.stockbloghub.com/2010/11/12/amln-amylin-pharmaceuticals-reports-wider-loss/59006/feed 0 http://www.stockbloghub.com/2010/10/15/bmy-bristol-myers-squibbs-pipeline-advances/55259 http://www.stockbloghub.com/2010/10/15/bmy-bristol-myers-squibbs-pipeline-advances/55259#comments Fri, 15 Oct 2010 18:02:12 +0000 vitalstocks http://www.stockbloghub.com/?p=55259 http://www.stockbloghub.com/2010/10/15/bmy-bristol-myers-squibbs-pipeline-advances/55259/feed 0 http://www.stockbloghub.com/2010/10/03/bmy-bristol-myers-squibb-trial-presents-encouraging-data/52798 http://www.stockbloghub.com/2010/10/03/bmy-bristol-myers-squibb-trial-presents-encouraging-data/52798#comments Mon, 04 Oct 2010 05:33:29 +0000 vitalstocks http://www.stockbloghub.com/?p=52798 http://www.stockbloghub.com/2010/10/03/bmy-bristol-myers-squibb-trial-presents-encouraging-data/52798/feed 0 http://www.stockbloghub.com/2010/09/21/bmy-bristol-myers-squibb-company-diabetes-drug-candidate-encourages/52428 http://www.stockbloghub.com/2010/09/21/bmy-bristol-myers-squibb-company-diabetes-drug-candidate-encourages/52428#comments Wed, 22 Sep 2010 03:17:16 +0000 vitalstocks http://www.stockbloghub.com/?p=52428 http://www.stockbloghub.com/2010/09/21/bmy-bristol-myers-squibb-company-diabetes-drug-candidate-encourages/52428/feed 0 http://www.stockbloghub.com/2010/08/10/alks-alkermes-earnings-report-shows-revenues-dipped/47206 http://www.stockbloghub.com/2010/08/10/alks-alkermes-earnings-report-shows-revenues-dipped/47206#comments Tue, 10 Aug 2010 17:40:46 +0000 vitalstocks http://www.stockbloghub.com/?p=47206 http://www.stockbloghub.com/2010/08/10/alks-alkermes-earnings-report-shows-revenues-dipped/47206/feed 0 http://www.stockbloghub.com/2010/06/29/alks-alkermes-amylin-pharmaceuticals-and-eli-lilly-see-encouraging-data-on-diabetes-candidate-bydureon/41922 http://www.stockbloghub.com/2010/06/29/alks-alkermes-amylin-pharmaceuticals-and-eli-lilly-see-encouraging-data-on-diabetes-candidate-bydureon/41922#comments Tue, 29 Jun 2010 18:02:40 +0000 vitalstocks http://www.stockbloghub.com/?p=41922 http://www.stockbloghub.com/2010/06/29/alks-alkermes-amylin-pharmaceuticals-and-eli-lilly-see-encouraging-data-on-diabetes-candidate-bydureon/41922/feed 0 http://www.stockbloghub.com/2010/06/28/bmy-bristol-myers-squibb-reports-encouraging-diabetes-therapy-data/41855 http://www.stockbloghub.com/2010/06/28/bmy-bristol-myers-squibb-reports-encouraging-diabetes-therapy-data/41855#comments Tue, 29 Jun 2010 00:04:22 +0000 vitalstocks http://www.stockbloghub.com/?p=41855 http://www.stockbloghub.com/2010/06/28/bmy-bristol-myers-squibb-reports-encouraging-diabetes-therapy-data/41855/feed 0 http://www.stockbloghub.com/2010/03/31/nvo-novo-nordisks-victoza-proves-more-effective/32423 http://www.stockbloghub.com/2010/03/31/nvo-novo-nordisks-victoza-proves-more-effective/32423#comments Wed, 31 Mar 2010 19:45:32 +0000 vitalstocks http://www.stockbloghub.com/?p=32423 http://www.stockbloghub.com/2010/03/31/nvo-novo-nordisks-victoza-proves-more-effective/32423/feed 0 http://www.stockbloghub.com/2010/03/16/amln-amylin-pharmaceuticals-drug-approval-delayed/30769 http://www.stockbloghub.com/2010/03/16/amln-amylin-pharmaceuticals-drug-approval-delayed/30769#comments Tue, 16 Mar 2010 21:44:07 +0000 vitalstocks http://www.stockbloghub.com/?p=30769 http://www.stockbloghub.com/2010/03/16/amln-amylin-pharmaceuticals-drug-approval-delayed/30769/feed 0 http://www.stockbloghub.com/2010/01/27/nvo-novo-nordisk-earns-us-food-and-drug-administration-for-diabetes-treatment/26216 http://www.stockbloghub.com/2010/01/27/nvo-novo-nordisk-earns-us-food-and-drug-administration-for-diabetes-treatment/26216#comments Thu, 28 Jan 2010 02:11:13 +0000 vitalstocks http://www.stockbloghub.com/?p=26216 http://www.stockbloghub.com/2010/01/27/nvo-novo-nordisk-earns-us-food-and-drug-administration-for-diabetes-treatment/26216/feed 0 http://www.stockbloghub.com/2010/01/11/mnkd-mannkind-corporation-gets-fda-setback/24632 http://www.stockbloghub.com/2010/01/11/mnkd-mannkind-corporation-gets-fda-setback/24632#comments Mon, 11 Jan 2010 22:29:15 +0000 vitalstocks http://www.stockbloghub.com/?p=24632 http://www.stockbloghub.com/2010/01/11/mnkd-mannkind-corporation-gets-fda-setback/24632/feed 0 http://www.stockbloghub.com/2010/01/06/mnkd-mannkind-awaits-us-food-and-drug-administration-decision/24338 http://www.stockbloghub.com/2010/01/06/mnkd-mannkind-awaits-us-food-and-drug-administration-decision/24338#comments Wed, 06 Jan 2010 23:57:04 +0000 vitalstocks http://www.stockbloghub.com/?p=24338 http://www.stockbloghub.com/2010/01/06/mnkd-mannkind-awaits-us-food-and-drug-administration-decision/24338/feed 0 http://www.stockbloghub.com/2009/12/16/amln-amylin-pharmaceuticals-impresses-in-head-to-head/23067 http://www.stockbloghub.com/2009/12/16/amln-amylin-pharmaceuticals-impresses-in-head-to-head/23067#comments Thu, 17 Dec 2009 05:21:45 +0000 vitalstocks http://www.stockbloghub.com/?p=23067 http://www.stockbloghub.com/2009/12/16/amln-amylin-pharmaceuticals-impresses-in-head-to-head/23067/feed 0 http://www.stockbloghub.com/2009/12/08/zgen-zymogenetics-inc-inks-licensing-deal-with-novo-nordisk-as/22228 http://www.stockbloghub.com/2009/12/08/zgen-zymogenetics-inc-inks-licensing-deal-with-novo-nordisk-as/22228#comments Tue, 08 Dec 2009 18:55:14 +0000 vitalstocks http://www.stockbloghub.com/?p=22228 http://www.stockbloghub.com/2009/12/08/zgen-zymogenetics-inc-inks-licensing-deal-with-novo-nordisk-as/22228/feed 0